(Q38910049)

7 September 2017

Functional impact of HIV coreceptor-binding site mutations (English)

1 reference

7 September 2017

0 references

1

Mark J Biscone

1 reference

7 September 2017

6

Robert W Doms

1 reference

7 September 2017

John L Miamidian

2

1 reference

7 September 2017

John M Muchiri

3

1 reference

7 September 2017

Sarah S W Baik

4

1 reference

7 September 2017

Fang-Hua Lee

5

1 reference

7 September 2017

Jacqueline D Reeves

7

1 reference

7 September 2017

language of work or name

English

0 references

publication date

21 April 2006

1 reference

7 September 2017

1 reference

7 September 2017

351

1 reference

7 September 2017

1

1 reference

7 September 2017

226-236

1 reference

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

7 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Core structure of gp41 from the HIV envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Expression cloning of new receptors used by simian and human immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Capture of an early fusion-active conformation of HIV-1 gp41

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

HIV fusion and its inhibition in antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

7 January 2021

V3: HIV's switch-hitter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Stable exposure of the coreceptor-binding site in a CD4-independent HIV-1 envelope protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Impact of mutations in the coreceptor binding site on human immunodeficiency virus type 1 fusion, infection, and entry inhibitor sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Rapid tumor formation and development of neutrophilia and splenomegaly in nude mice transplanted with human cells expressing human T cell leukemia virus type I or Tax1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

Effects of irradiation on cytokine production in glioma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.03.017

1 reference

7 September 2017

1 reference